FDA Approves First Muscle-Targeted Therapy for SMA

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Critical Safeguards: “In Case of Emergency” in Neuromuscular Disease

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Friday, October 24, 2025

Faculty

Beth Kaufman, MD
Clinical Professor, Pediatrics

Stanford University School of Medicine

Jennifer Kwon, MD, MPH
Director, Pediatric Neuromuscular Program

University of Wisconsin – American Family Children’s Hospital

Daniel L. Menkes, MD, MHSA
Professor and Chair of Neurology

Oakland University William Beaumont School of Medicine

Carrie K Barker, MD
Pediatric Pulmonology

University of Wisconsin – Madison

Activity Overview: 

This webinar will explore case examples of scenarios associated with increased risk in emergency care for neuromuscular disease, adopt evidence-based protocols to manage these high-risk situations, and develop communication strategies to help patients take appropriate precautions in ER settings.

Learning Objectives: 

Identify scenarios associated with increased risk for NMD patients in ER settings.
Consider potential knowledge gaps/challenges among ER teams that impact NMD care.
Develop communication strategies with community providers and patients to help prevent acute care missteps.

Accreditation and Designation Statement: 
How to Obtain CME credits : 

Access CE dashboard here.

Login or Create an account in the system. (All 1st time users are required to create an account)

Proceed to “Register/Take Course” Tab to complete the Course Evaluation & Certificate steps for the activity.

If you have questions about this CE activity, please contact AKH Inc at bethany@akhcme.com.

Faculty Disclosures: 

View faculty disclosures here

Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with "Opt Out" in the subject line.